Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial

Peer Review reports

Original Submission
24 Oct 2018	Submitted	Original manuscript
26 Nov 2018	Reviewed	Reviewer Report - Mariusz Chabowski
15 Jan 2019	Reviewed	Reviewer Report - Bach Duc-Hiep
10 Apr 2019	Author responded	Author comments - Daniel Preto
Resubmission - Version 2
10 Apr 2019	Submitted	Manuscript version 2
Publishing
11 Apr 2019	Editorially accepted
25 Apr 2019	Article published	10.1186/s12885-019-5599-z

Back to article page